Hyperlipidaemia in patients with HIV-1 infection receiving highly active antiretroviral therapy: epidemiology, pathogenesis, clinical course and management

By Calza L.   Manfredi R.   Chiodo F.  

International Journal of Antimicrobial Agents, Vol. 22, Iss. 2, 2003-08 ,pp. : 89-99

Elsevier

Access to resources Recommend Favorite

Critical issues of HIV treatment in the era of highly active antiretroviral therapy

By Battegay M.  

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 175-183

Informa Healthcare

Access to resources Recommend Favorite

Facilitating Adherence to Highly Active Antiretroviral Therapy in Children with HIV Infection: What Are the Issues and What Can Be Done?

By Pontali Emanuele  

Pediatric Drugs, Vol. 7, Iss. 3, 2005-01 ,pp. : 137-149

Adis International

Access to resources Recommend Favorite

Emerging Drug Toxicities of Highly Active Antiretroviral Therapy for HumanImmunodeficiency Virus (HIV) Infection

By  

Current Drug Targets, Vol. 4, Iss. 1, 2003-01 ,pp. : 13-22

Bentham Science Publishers

Access to resources Recommend Favorite

Highly Active Antiretroviral Therapy and Cardiovascular Complications in HIV-Infected Patients

By  

Current Pharmaceutical Design, Vol. 9, Iss. 18, 2003-07 ,pp. : 1475-1481

Bentham Science Publishers

Access to resources Recommend Favorite